期刊文献+

降钙素原检测对脓毒症病情及预后判断的指导价值(附46例分析) 被引量:6

Clinical significance of the surum PCT in assessing the severity and prognosis of the patients with sepsis:Analysis of 46 cases
下载PDF
导出
摘要 目的探讨血清降钙素原(PCT)检测对脓毒症病情及预后判断的指导价值。方法 46例脓毒症患者按病情轻重分早期脓毒症组、严重脓毒症组和脓毒症休克组,分别比较组间血清PCT、C反应蛋白(CRP)、WBC和急性生理与慢性健康状况评分(APACHEⅡ),并行PCT与APACHEⅡ评分相关性分析;同时按PCT水平,分为PCT<5.0、5.0~<10.0、PCT≥10.0ng/mL 3组,比较各组的病死率、抗生素使用时间、住院时间和外周血培养结果。结果脓毒症休克组与其他两组比较,PCT、CRP、WBC和APACHEⅡ评分差异均有统计学意义(P<0.05);严重脓毒症组与早期脓毒症组比较,PCT、CRP、APACHEⅡ差异有统计学意义(P<0.05),WBC差异无统计学意义(P>0.05),PCT与APACHEⅡ评分之间呈显著正相关(r=0.68,P<0.05);随着PCT水平升高,脓毒症患者病死率呈增高趋势,抗生素使用时间及住院时间延长(P<0.05),同时血培养阳性率升高。结论血PCT对脓毒症病情判断及评估预后有一定指导意义。 Objective To evaluate the significance of serum procalcitonin (PCT) for estimation of severity and prognosis in patients with sepsis. Methods A total of 46 patients with sepsis were divided into three groups according to clinical severity.. early sepsis group, sever sepsis group and septic shock group. To study the difference of serum PCT, CRP, WBC and A- PACHE Ⅱscores in all groups and explore the prognostic significance of the biological markers, and correlation was analyzed be- tween PCT and APACHE Ⅱ scores. Meanwhile, all patients were divided into three groups depending on different levels of ser- um PCT 〈5 ng/mL group, 5.0-〈10.0 ng/mL group, ≥10.0 ng/mL group. The mortality, the length of using antibiotics and hospital stay were analyzed. At the same time, the samples were performed the blood culture. Results The levels of PCT, CRP, WBC and APACHEⅡ scores in septic shock were significantly higher than the severe sepsis group and the early sepsis group, compared the difference was significant (P〈0.05). The levels of PCT, CRP and APACHEⅡ scores were significantly different between early sepsis group and severe sepsis group (P〈0.05), however, the level of WBC was not (P〈0.05), and significant positive correlation between PCT and APACHEⅡ (r=0. 68, P〈0.05) was found. With increasing PCT levels, the morbidity, the length of using antibiotics and hospital stay increased (P〈0.05), and the positive rate of the blood culture also improved. Conclusion Detecting serum PCT can be useful for assessment of severity and prognosis in patients with sepsis.
出处 《福建医药杂志》 CAS 2013年第1期61-63,共3页 Fujian Medical Journal
关键词 降钙素原 脓毒症 病情及预后 procalcitonin sepsis severity and prognosis
  • 相关文献

参考文献11

  • 1Angus D C,Linde-Zwirble W T,Lidicker J. Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Critical Care Medicine,2001,(07):1303-1310.
  • 2Levy M M,Fink M P,Marshall J C. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J].Critical Care Medicine,2003,(04):1250.
  • 3Guibourdenche J,Bedu A,Petzold L. Biochemical markers neonatal sepsis:value of procalcitonin in the emergency setting[J].Annals of Clinical Biochemistry,2002,(Pt 2):130-135.
  • 4Maruna P,Nedelnikova K,Gurlich R. Physiology and genetics of procalcitonin[J].Physjol Res,2000,(Suppl.1):57-61.
  • 5Suarez-Santamaria M,Santolaria F,Perez-Ramirez A. Prognostic value of inflammatory markers(notably cytokines and procalcitonin),nutritional assessment,and organ function in patients with sepsis[J].European Cytokine Network,2010,(01):19.
  • 6吴丽娟,鲁涛,尹培刚,陈德生,陈福成.脓毒血症患者血浆降钙素原的变化及其意义[J].中日友好医院学报,2004,18(2):73-76. 被引量:31
  • 7Luzzani A,Polati E,Dorizzi R. Comparison of procalcitonin and reactive protein as markers of sepsis[J].Critical Care Medicine,2003,(06):1737-1741.
  • 8梁建业.第3代危重患者病情评价系统——APACHE、SAPSⅡ和MPMⅡ[J].中国危重病急救医学,2000,12(4):249-253. 被引量:53
  • 9Ghorbani G. Procalcitonin role in differential diagnosis of infection stages and non infection inflammation[J].Pakistan Journal of Biological Sciences,2009,(04):393-396.
  • 10孙长贵,杨燕,陈坚,林迪,成军,张丽君.5356例血培养病原菌分布及耐药性分析[J].浙江临床医学,2012,14(5):530-532. 被引量:13

二级参考文献28

  • 1黄晓丽,王国品,王智,刘顺英.重症急性胰腺炎合并肺损伤大鼠血清PCT的变化及其意义[J].中国厂矿医学,2009,22(1):7-9. 被引量:1
  • 2梁建业.危重病患者病情评定法——APACHE系统的研究进展[J].中国危重病急救医学,1996,8(1):52-56. 被引量:65
  • 3[2]Brunkhorst FM,Wegscheider K,Forychi ZF,et al.Procalcitonin for early diagnosis and differentiation of SIRS,sepsis,severe sepsis,and septic shock[J].Intensive Care Med,2000,26(Suppl 2):148-152.
  • 4[3]Eberhard OK,Langefeld I,Kuse ER,et al.Procalcitonin in the early phase after renal transplantation -will it add to diagnostic accuracy[J]? Clin Transplant,1998,12(3):206-211 .
  • 5[4]Brunkhorst FM,Eberhard OK,Brunkhorst R,et al.Discrimination of infectious and non-infectious causes of early acute respiratory distress syndrome by procalcitonin[J].Crit Care Med,1999,27(10):2172-2176.
  • 6[5]American College of Chest Phsicians/Society of Critical Care Medicine Consensus Conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Crit Care Med,1992,20(6):864-874.
  • 7[6]Knaus WA,Draper EA,Wagner DP,et al.APACHEⅡ:A severity of disease classification system[J]. Crit Care Med,1985,13(10):818-829.
  • 8[7]Oberhoffer M,Ruwurm S,Bredle D,et al.Discriminative power of inflammatory markers for prediction of tumor necrosis factor-αand interleukin-6 in ICU patients with systemic inflammatory response syndrome(SIRS) or sepsis at arbitrary time points[J].Intensive Care Med,2000,26(Suppl 2):170-174.
  • 9[8]Meisner M,Tschaikowsky K,Palmaers T,et al.Procalcitonin and CRP inseptic shock:inflammatory parameters with different kinetics[J].Intensive Care Med,1996,22(Suppl 1):14.
  • 10[9]Reith HB,Mittelkotter U,Wagner R,et al.Procalcitonin(PCT) in patients with abdominal sepsis[J]. Intensive Care Med,2000,26(Suppl 2):165-169.

共引文献107

同被引文献59

  • 1滕国杰,聂秀红.脓毒症患者单个核细胞Toll样受体4表达与内毒素耐受的关系[J].中华临床医师杂志(电子版),2011,5(18):5319-5322. 被引量:3
  • 2Goldstein B, Giroir B, Randolph A, et al. International pedi- atric sepsis consensus conference:definitions for sepsis and or- gan dysfunction in pediatrics [J]. Pediatr Crit Care Med, 2005, 6(1): 2.
  • 3Schroeder S, Hochreiter M, Koehler T, et al. Procaleitonin (P(TT)- guided algorithm reduces length of antibiotic treat- ment in surgical intensive care patients with severe sepsis:re-suits of a prospective randomized study[J ]. Langenbecks Arch Surg, 2009, 394(2): 221.
  • 4AI - Tehewy M, E1 Houinie M, E1 - Ezz N A, et al. De- veloping severity adjusted quality measures for intensive care units[J]. Int J Health Care Qual Assur, 2010, 23(3) : 277.
  • 5Watson R S, Carcillo J A, Linde - Zwirble W T, et al. The epidemiology of severe sepsis in children in the United States [J].Am J Respir Crit Care Med, 2003, 167(5): 695.
  • 6Marshall JC, Vincent JL, Guyatt G, et al. Outcome measures for clinical research in sepsis : a report of the 2nd cambridge colloquium of the international sepsis forum[ J ]. Crit Cale Med , 2005,33 (8) : 1708 - 1716.
  • 7Martin GS. Sepsis, severe sepsis and septic shock: changes in inci- dence, pathogens and outcomes [ J]. Expert Rev Anti Infect Ther, 2012, 10(6) :701 -706.
  • 8Memebers of the American College of Chest Physicians/Society of CritCare Med Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Confer- ence: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [ J]. Clqt Care Med, 1992, 20 (6) :864 - 874.
  • 9Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/AC- CP/ATS/SIS international sepsis definitions colfferenee[ J ]. Crit Ca Med, 2003, 31 (4) :1250 - 1256.
  • 10Poeze M, Ramsay G, Gerlach H, et al. An international sepsis sur- vey: a study of doctors knowledge and perception about sepsis [ J ]. Crit Care,2004, 8(6) :R409 - R413.

引证文献6

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部